About Michael Layman
Form D filings for Clarametyx Biosciences in 2024 list Michael Layman as director.
Michael Layman first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Layman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Layman works with at each company, as listed on that company's latest Form D.
Clarametyx Biosciences, Inc. · Form D, Jan 19, 2024
DR
David Richards
Chief Executive Officer
PK
Peter Kleinhenz
Director
WB
William Baumel
Director
WE
Wayne Embree
Director
CB
Chuck Bramlage
Director
LE
Larry Edwards
Director
MI
Michael Triplett II
Director